Good Morning America reporter Amy Robach was diagnosed with breast cancer at age 40 after receiving her first mammogram. For Memorial Sloan-Kettering experts, the message behind this story bears repeating: Mammograms save lives.
Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton was interviewed on PBS NewsHour about a recent recommendation from a National Cancer Institute working group that proposed changing the definition of cancer.
A New York State law that went into effect this month requires radiologists to inform women if they have dense breasts. Dr. Lee answers questions about the concept of breast density and what women should know.
New, potentially practice-changing research sheds light on the long-term benefits of estrogen-blocking tamoxifen therapy in women with early-stage breast cancer whose disease is estrogen-receptor positive.
A new Memorial Sloan-Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.
A team of investigators from Memorial Sloan-Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
Dr. Morrow, Chief of Memorial Sloan-Kettering’s Breast Surgical Service, discusses how our patients with breast cancer are cared for by a true team of experts in every aspect of treatment and recovery.
A new study confirms that female childhood cancer survivors who were treated with radiation to the chest have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes.
Dr. Morrow is the first surgeon and the first person from Memorial Sloan-Kettering to receive the American Society of Clinical Oncology’s award, which recognizes breast cancer researchers who are also excellent mentors.
Memorial Sloan-Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove small breast cancers.
Breast Surgical Service Chief Monica Morrow provides perspective on assessing the quality of surgical breast cancer treatment in an editorial in the February 1 issue of the Journal of the American Medical Association.
Memorial Sloan-Kettering medical oncologist Clifford A. Hudis has been elected President of the American Society of Clinical Oncology, the world’s leading professional organization representing more than 30,000 physicians who care for people with cancer.
Medical oncologist Heather McArthur discussed why an individualized approach is important in treating cancer as well as her research in immunotherapy. Gynecologist Noah Kauff discussed the risks and recommendations for women with BRCA gene mutations.
A Memorial Sloan-Kettering patient shared her decision to have a preventative double mastectomy after learning she’s BRCA1-positive in this documentary series. Her breast surgeon Mary Gemignani, plastic surgeon Andrea Pusic, and genetic counselor Mark Robson were all featured in the film.
Medical oncologist Andrew Seidman discussed Memorial Sloan-Kettering’s collaboration with IBM Watson and the benefits it will bring to treating patients, and medical oncologist Victoria Blinder discussed psycho-social issues that can come into play when a person is going through cancer treatment.
Memorial Sloan-Kettering Physician-in-Chief José Baselga commented on the recommendation from a federal advisory panel to approve the first drug that would be used in early-stage breast cancer patients, prior to surgery.
Surgical oncologist Monica Morrow discussed a study she co-authored that found that more than three-quarters of women who opt for double mastectomies are not getting any benefit because their risk of cancer developing in the healthy breast is no greater than in women without cancer.
Diagnostic radiologist Carol Lee discussed a study that analyzed 30 years of data on breast cancer incidence and suggested that as many as a third of cancers detected through routine mammograms may not be life threatening. Epidemiologist Colin Begg also commented on the study in Reuters and Nature, and Memorial Sloan-Kettering’s Breast Disease Management Team authored a letter to the editor about the study that was published in the New York Times.